149
Views
2
CrossRef citations to date
0
Altmetric
Original Research

The Value of Impulse Oscillometric Parameters and Quantitative HRCT Parameters in Differentiating Asthma–COPD Overlap from COPD

ORCID Icon, , , , , & show all
Pages 2883-2894 | Published online: 19 Oct 2021

References

  • Woodruff PG, van den Berge M, Boucher RC, et al. American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report. Am J Resp Crit Care. 2017;196(3):375–381. doi:10.1164/rccm.201705-0973WS
  • Global Initiative for Asthma [webpage on the Internet]. Global strategy for asthma management and prevention. Available from: http://www.ginasthma.org. Accessed April 30, 2018.
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2018 [webpage on the Internet]. The Global Strategy for the Diagnosis, Management and Prevention of COPD. Available from: http://www.goldcopd.org. Accessed April 30, 2018.
  • Agusti A, Fabbri LM, Singh D, et al. Inhaled corticosteroids in COPD: friend or foe? Eur Respir J. 2018;52:6. doi:10.1183/13993003.01219-2018
  • Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Resp Med. 2013;107(7):1053–1060. doi:10.1016/j.rmed.2013.03.007
  • Cosio BG, Soriano JB, López-Campos JL, et al. Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest. 2016;149(1):45–52. doi:10.1378/chest.15-1055
  • Sin DD, Miravitlles M, Mannino DM, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J. 2016;48(3):664–673.
  • Tommola M, Ilmarinen P, Tuomisto LE, et al. Differences between asthma-COPD overlap syndrome and adult-onset asthma. Eur Respir J. 2017;49(5). doi:10.1183/13993003.02383-2016
  • Menezes A, Montes de Oca, M., Pérez-Padilla, R., et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145(2):297–304. doi:10.1378/chest.13-0622
  • Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. COPD. 2011;8(6):400–407. doi:10.3109/15412555.2011.611200
  • Global Initiative for Asthma, Global Initiative for Chronic Obstructive Lung Disease [webpage on the Internet]. Diagnosis and initial treatment of asthma, COPD, and asthma-COPD overlap. Available from: http://ginasthma.org/download/824/. Accessed July 1, 2019.
  • Bickel S, Popler J, Lesnick B, Eid N. Impulse oscillometry: interpretation and practical applications. Chest. 2014;146(3):841–847. doi:10.1378/chest.13-1875
  • Mori K, Shirai T, Mikamo M, et al. Colored 3-dimensional analyses of respiratory resistance and reactance in COPD and asthma. COPD. 2011;8(6):456–463. doi:10.3109/15412555.2011.626818
  • Bhattarai P, Myers S, Chia C, et al. Clinical application of Forced Oscillation Technique (FOT) in early detection of airway changes in smokers. J Clin Med. 2020;9(9). doi:10.3390/jcm9092778
  • Shinke H, Yamamoto M, Hazeki N, et al. Visualized changes in respiratory resistance and reactance along a time axis in smokers: a cross-sectional study. Respir Investig. 2013;51(3):166–174. doi:10.1016/j.resinv.2013.02.006
  • Ling W, Pengbo S, Lihua Z, et al. Diagnostic value of impulse oscillometry system in patients with asthma-chronic obstructive pulmonary disease. Int J Respir. 2020;8:341–348.
  • Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5). doi:10.1183/13993003.00164-2019
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Oostveen E, MacLeod D, Lorino H, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003;22(6):1026–1041. doi:10.1183/09031936.03.00089403
  • Cottini M, Licini A, Lombardi C, et al. Clinical characterization and predictors of IOS-defined small-airway dysfunction in asthma. J Allergy Clin Immunol Pract. 2020;8(3):997–1004.
  • Gevenois PA, de Maertelaer V, De Vuyst P, et al. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med. 1995;152(2):653–657. doi:10.1164/ajrccm.152.2.7633722
  • Matsuoka S, Kurihara Y, Yagihashi K, et al. Quantitative assessment of air trapping in chronic obstructive pulmonary disease using inspiratory and expiratory volumetric MDCT. AJR Am J Roentgenol. 2008;190(3):762–769. doi:10.2214/AJR.07.2820
  • O’Donnell RA, Peebles C, Ward JA, et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax. 2004;59(10):837–842. doi:10.1136/thx.2003.019349
  • Kubo K, Eda S, Yamamoto H, et al. Expiratory and inspiratory chest computed tomography and pulmonary function tests in cigarette smokers. Eur Respir J. 1999;13(2):252–256. doi:10.1034/j.1399-3003.1999.13b06.x
  • Nambu A, Zach J, Schroeder J, et al. Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: relationship to physiological measurements, clinical index and visual assessment of airway disease. Eur J Radiol. 2016;85(11):2144–2151. doi:10.1016/j.ejrad.2016.09.010
  • Schroeder JD, McKenzie AS, Zach JA, et al. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. AJR Am J Roentgenol. 2013;201(3): W460–W470. doi:10.2214/AJR.12.10102
  • Hartley RA, Barker BL, Newby C, et al. Relationship between lung function and quantitative computed tomographic parameters of airway remodeling, air trapping, and emphysema in patients with asthma and chronic obstructive pulmonary disease: a single-center study. J Allergy Clin Immunol. 2016;137(5):1413–1422. doi:10.1016/j.jaci.2016.02.001
  • Scichilone N, Benfante A, Morandi L, et al. Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD. Patient Relat Outcome Meas. 2014;5:153–162.
  • McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567–1575. doi:10.1056/NEJMoa1106955
  • Barrecheguren M, Pinto L, Mostafavi-Pour-Manshadi SM, et al. Identification and definition of asthma-COPD overlap: the CanCOLD study. Respirology. 2020;25(8):836–849. doi:10.1111/resp.13780
  • Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J. 2014;44(2):341–350. doi:10.1183/09031936.00216013
  • Karayama M, Inui N, Yasui H, et al. Physiological and morphological differences of airways between COPD and asthma-COPD overlap. Sci Rep. 2019;9(1):7818. doi:10.1038/s41598-019-44345-6
  • Joo H, Han D, Lee JH, et al. Heterogeneity of asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2017;12:697–703. doi:10.2147/COPD.S130943